A Phase II, Open-Label, Mutli-Center Study to Assess the Tolerance, Safety, Efficacy and Pharmacokinetics: POL7080002

Project Details

StatusFinished
Effective start/end date12/02/141/07/15

Funding

  • Other (Learned Society): £2,986.00